These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27804107)

  • 1. Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.
    Lazaridis KN
    Clin Pharmacol Ther; 2017 Jan; 101(1):39-41. PubMed ID: 27804107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.
    O'Donnell PH; Bush A; Spitz J; Danahey K; Saner D; Das S; Cox NJ; Ratain MJ
    Clin Pharmacol Ther; 2012 Oct; 92(4):446-9. PubMed ID: 22929923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress and Challenges in Pharmacogenomics.
    Van Driest SL; Cascorbi I
    Clin Pharmacol Ther; 2021 Sep; 110(3):529-532. PubMed ID: 34412159
    [No Abstract]   [Full Text] [Related]  

  • 4. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving pharmacotherapy outcomes by pharmacogenomics: from expectation to reality?
    Vizirianakis IS
    Pharmacogenomics; 2005 Oct; 6(7):701-11. PubMed ID: 16207147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
    Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
    Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in pharmacotherapy for older adults: a framework for pharmacogenomics implementation.
    Roman YM; Dixon DL; Salgado TM; Price ET; Zimmerman KM; Sargent L; Slattum PW
    Pharmacogenomics; 2020 Jun; 21(9):627-635. PubMed ID: 32425117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics and individualized medicine: translating science into practice.
    Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
    Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic predisposition to adverse drug reactions in the intensive care unit.
    Empey PE
    Crit Care Med; 2010 Jun; 38(6 Suppl):S106-16. PubMed ID: 20502164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Canadian Pharmacogenomics Network for Drug Safety: a model for safety pharmacology.
    Ross CJ; Visscher H; Sistonen J; Brunham LR; Pussegoda K; Loo TT; Rieder MJ; Koren G; Carleton BC; Hayden MR;
    Thyroid; 2010 Jul; 20(7):681-7. PubMed ID: 20578893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of pharmacogenomics in product information.
    Skvrce NM; Krivokapić S; Božina N
    Pharmacogenomics; 2020 May; 21(7):443-448. PubMed ID: 32336208
    [No Abstract]   [Full Text] [Related]  

  • 13. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
    Trent RJ; Cheong PL; Chua EW; Kennedy MA
    Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
    Dunnenberger HM; Crews KR; Hoffman JM; Caudle KE; Broeckel U; Howard SC; Hunkler RJ; Klein TE; Evans WE; Relling MV
    Annu Rev Pharmacol Toxicol; 2015; 55():89-106. PubMed ID: 25292429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics: Precision Medicine and Drug Response.
    Weinshilboum RM; Wang L
    Mayo Clin Proc; 2017 Nov; 92(11):1711-1722. PubMed ID: 29101939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice.
    Manolopoulos VG
    Clin Chem Lab Med; 2007; 45(7):801-14. PubMed ID: 17617019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics: bridging the gap between science and practice.
    Lee KC; Ma JD; Kuo GM
    J Am Pharm Assoc (2003); 2010; 50(1):e1-14; quiz e15-7. PubMed ID: 20368146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biobanking and pharmacogenomics.
    McCarty CA; Wilke RA
    Pharmacogenomics; 2010 May; 11(5):637-41. PubMed ID: 20415552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacogenomics].
    Nakatani K; Nobori T
    Rinsho Byori; 2013 Nov; 61(11):1018-25. PubMed ID: 24450107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.